Provided by Tiger Trade Technology Pte. Ltd.

Treace Medical Concepts, Inc.

4.34
-0.1200-2.69%
Post-market: 4.400.0600+1.38%19:30 EDT
Volume:277.51K
Turnover:1.22M
Market Cap:282.25M
PE:-4.69
High:4.54
Open:4.46
Low:4.28
Close:4.46
52wk High:7.78
52wk Low:1.17
Shares:65.03M
Float Shares:46.95M
Volume Ratio:1.04
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9262
EPS(LYR):-0.9326
ROE:-71.99%
ROA:-17.33%
PB:4.17
PE(LYR):-4.65

Loading ...

Truist Financial Reaffirms Their Hold Rating on Treace Medical Concepts (TMCI)

TIPRANKS
·
Aug 10

Axsome Therapeutics Q2 Revenue Rises on Auvelity Growth

Reuters
·
Aug 10

Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating

MT Newswires Live
·
Aug 10

AirSculpt Q2 Revenue Falls More than Expected

Reuters
·
Aug 10

Treace Medical Rises After Earnings Beat, Raised Outlook

Dow Jones
·
Aug 07

Treace Medical Concepts, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Treace Medical Q2 Revenue Tops Estimates on Higher Surgeon Adoption; Ups Outlook

Reuters
·
Aug 07

Treace Medical Q2 Net Loss Narrows to $15.9 Million; Revenue Falls 4% to $45.4 Million

Reuters
·
Aug 07

Treace Medical Concepts Q2 EPS $(0.24) Beats $(0.30) Estimate, Sales $45.376M Beat $44.020M Estimate

Benzinga Earnings
·
Aug 07

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 07

Treace Medical Q2 EPS USD -0.24

THOMSON REUTERS
·
Aug 07

Treace Medical Outlook FY Revenue USD 204-212 Million VS. Ibes Estimate USD 206.2 Million

THOMSON REUTERS
·
Aug 07

Treace Medical Q2 Gross Margin 78.5%

THOMSON REUTERS
·
Aug 07

Treace Medical Concepts, - Reiterates Expectation for 50% Reduction in Fy2026 Cash Usage vs 2025

THOMSON REUTERS
·
Aug 07

Treace Medical Concepts, Inc. Expected to Post a Loss of 30 Cents a Share - Earnings Preview

Reuters
·
Aug 05

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

GlobeNewswire
·
Jul 24

Treace Medical Concepts is Maintained at Hold by Truist Securities

Dow Jones
·
Jul 17

Truist Securities Adjusts Price Target on Treace Medical Concepts to $4 From $2, Maintains Hold Rating

MT Newswires Live
·
Jul 16

Ossdsign Names Adam Mccollister Vice President of Sales

Reuters
·
Jun 25

Treace Medical announces first surgical case with HyperPlate XM implant

TIPRANKS
·
Jun 18